MICHELLE JASPER: Open Payments
NPI 1164786273 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$280 in 15 payments from 7 companies in 2025. Trend: 2023 $1,571 · 2024 $475 · 2025 $280
Food & beverage: $280
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $82 |
| ABBVIE INC. | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
| Dexcom, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, Wegovy, Ozempic, REXULTI, MOUNJARO, TZIELD, Dexcom G6 Transmitter, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
